Skip to main content

Release of Vasoactive Substances in Ascites and Blood in Acute Pancreatitis

  • Chapter

Abstract

Acute pancreatitis is a disease with many questions still unanswered concerning both aetiology, pathophysiology and treatment.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lee WK, Frasca M, Lee C, Haider B, Regan TJ (1981) Depression of myocardial function during acute pancreatitis. Circ Shock 8:369–374

    PubMed  CAS  Google Scholar 

  2. Renner IG, Rinderknecht H, Douglas AP (1978) Profiles of pure pancreatic secretions in patients with acute pancreatitis: the possible role of proteolytic enzymes in pathogenesis. Gastroenterology 75:1090–1098

    PubMed  CAS  Google Scholar 

  3. Borgström A, Ohlsson K (1978) Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe-Seylers Z Physiol Chem 359:677–681

    PubMed  Google Scholar 

  4. Brodrick JW, Geokas MC, Largman C, Fassett M, Johnson JH (1979) Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. Am J Physiol 237: E474–E480

    PubMed  CAS  Google Scholar 

  5. Toki N, Takasugi S, Sumi H (1982) Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis. Clin Sci 62:321–328

    PubMed  CAS  Google Scholar 

  6. Carey LC (1979) Extra-abdominal manifestions of acute pancreatitis. Surgery 86:337 –342

    PubMed  CAS  Google Scholar 

  7. Ofstad E (1970) Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs. Scand J Gastroenterology 5 [Suppl 5):7–44

    Google Scholar 

  8. Felgenhauer K, Schliep G, Rapic N (1976) Protein permeability of the blood-CSF barrier. In: Peeters H (ed) Protides of the biological fluids. Pergamon, Oxford, P 481

    Google Scholar 

  9. Kolb WP, Haxby JA, Arroyave CM, Müller-Eberhard JH (1973) The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. J Exp Med 138:428–437

    Article  PubMed  CAS  Google Scholar 

  10. Seelig R, Ehemann V, Tschahargane C, Seelig HP (1975) The serum complement system — a mediator of acute pancreatitis. Virchows Arch [A] 365:193–199

    Article  CAS  Google Scholar 

  11. Jacob HS, Goldstein IM, Shapiro I, Craddock PR, Hammerschmidt DE, Weissmann G (1981) Sudden blindness in acute pancreatitis. Arch Intern Med 141:134–136

    Article  PubMed  CAS  Google Scholar 

  12. van Vliet ACM, van Vliet HDM, Dzoljic-Danilovic G, Wilson JHP (1981) Plasma pre- kallikrein and endotoxemia in liver cirrhosis. Thromb Haemostas 45:65–67

    Google Scholar 

  13. Rocha e Silva M, Beraldo WT, Rosenfeld G (1949) Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 156:261–273

    Google Scholar 

  14. Ryan US, Ryan JW, Whitaker C (1979) How do kinins affect vascular tone? Adv Exp Med Biol 120 A: 375–389

    Google Scholar 

  15. Takada Y, Appert HE, Howard JM (1976) Vascular permeability induced by pancreatic exudate formed during acute pancreatitis in dogs. Surg Gynecol Obstet 143:779–783

    PubMed  CAS  Google Scholar 

  16. Dietze GJ, Wicklmayr M, Lichtneckert E, Schifman R, Waczek SL, Brunnbauer S, Boettger I, Geiger R, Fritz H, Mehnert H (1982) Evidence for an involvement of kinins and prostaglandins in the modulation of the action of insulin induced by changes of the energy state in skeletal muscle tissue. In: McConn R (ed) Role of chemical mediators in the pathophysiology of acute illness and injury. Raven, New York, p 297

    Google Scholar 

  17. Chan JYC, Movat HZ, Burrowes CE (1979) High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin. Thromb Res 14:817–824

    Article  PubMed  CAS  Google Scholar 

  18. Johnson U, Ohlsson K, Olsson I (1976) Effects of granulocyte neutral proteases on complement components. Scand J Immunol 5:421–426

    Article  PubMed  CAS  Google Scholar 

  19. Wuepper KD, Miller DR, Lacombe MS, Flaujec T (1975) Deficiency of human plasma kininogen. J Clin Invest 56:1663–1672

    Article  PubMed  CAS  Google Scholar 

  20. Gallimore MJ, Amundsen E, Larsbraaten M, Lyngaas K, Fareid E (1979) Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays. Thromb Res 16:695–703

    Article  PubMed  CAS  Google Scholar 

  21. Shapira M, Scott CF, Colman RW (1982) Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 69:462–468

    Article  Google Scholar 

  22. Aasen AO, Smith-Erichsen N, Amundsen E (1983) Plasma kallikrein-kinin system in septicemia. Arch Surg 118:343–346

    Article  PubMed  CAS  Google Scholar 

  23. Aasen AO, Kierulf P, Vaage J, Grodal HC, Aune S (1983) Determination of components of the plasma proteolytic enzyme system gives information of prognostic value in patients with multiple trauma. Adv Exp Med Biol 156B: 1037–1047

    Google Scholar 

  24. McConn R, Wasserman F, Haberland G (1982) The kallikrein-kinin system in the acutely ill: changes in plasma kininogen in acutely ill patients and the efficacy of pulmonary clearance of bradykinin. In: McConn R (ed) Role of chemical mediators in the pathophysiology of acute illness and injury. Raven, New York, p 11

    Google Scholar 

  25. Colman RW, Wong PY (1977) Participation of Hageman factor dependent pathways in human disease states. Thromb Haemostas 38:751–767

    CAS  Google Scholar 

  26. Laureil CB (1972) Electroimmunoassay. Scand J Clin Lab Invest 29 (Suppl 124):21–37

    Article  CAS  Google Scholar 

  27. Sjöholm AG (1975) Complement components in normal sefum and plasma quantitated by electroimmunoassay. Scand J Immunol 4:25–30

    Article  PubMed  Google Scholar 

  28. Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254

    Article  PubMed  CAS  Google Scholar 

  29. Borgström A, Ohlsson K (1984) A method for determination of immunoreactive trypsin in complex with α1-antitrypsin in human sera. Scand J Clin Lab Invest 44:381–386

    Article  PubMed  Google Scholar 

  30. Gallimore MJ, Friberger P (1982) Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “ike” activity in human plasma. Thromb Res 25:293–298

    Article  PubMed  CAS  Google Scholar 

  31. Lämmle B, Eichlisberger RE, Marbet G A, Duckert F (1979) Amidolytic activity in normal human plasma assessed with chromogenic substrates. Thromb Res 16:245–254

    Article  PubMed  Google Scholar 

  32. Stormorken H, Baklund A, Gallimore M, Ritland S (1978) Chromogenic substrate assay of plasma prekallikrein. Haemostasis 7:69–75

    PubMed  CAS  Google Scholar 

  33. Diniz CR, Carvalho IF (1963) A micromethod for determination of bradykininogen under several conditions. Ann NY Acad Sci 104:77–89

    Article  PubMed  CAS  Google Scholar 

  34. Ganrot PO (1972) Crossed Immunoelectrophoresis. Scand J Clin Lab Invest 29 [Suppl 124]: 39–47

    Article  CAS  Google Scholar 

  35. Borgström A, Lasson Å (1984) Trypsin-alpha1-protease inhibitor complexes in serum and clinical course of acute pancreatitis. Scand J Gastroenterol 19:1119–1122

    PubMed  Google Scholar 

  36. Lasson Å, Laurell AB, Ohlsson K (1985) Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man. Scand J Gastroenterol 20:335–345

    Article  PubMed  CAS  Google Scholar 

  37. Lasson Å, Ohlsson K (1984) Changes in the kallikrein kinin system during acute pancreatitis in man. Thromb Res 35:27–41

    Article  PubMed  CAS  Google Scholar 

  38. Lasson Å, Balldin G, Ohlsson K (1986) Leucocyte elastase-α1-proteinase inhibitor complexes may diagnose pancreatic abscesses early. Scand J Gastroenterol (to be published)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Balldin, G. (1987). Release of Vasoactive Substances in Ascites and Blood in Acute Pancreatitis. In: Beger, H.G., Büchler, M. (eds) Acute Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83027-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83027-3_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83029-7

  • Online ISBN: 978-3-642-83027-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics